Clinical Trials Logo

Pain, Postoperative clinical trials

View clinical trials related to Pain, Postoperative.

Filter by:

NCT ID: NCT04751344 Recruiting - Postoperative Pain Clinical Trials

Liposomal Bupivacaine Versus Bupivacaine Plain for Operative Pain Management of Forefoot Surgery

Start date: June 16, 2020
Phase: Phase 4
Study type: Interventional

Prospective, randomized, controlled single-blinded trial comparing liposomal bupivacaine with bupivacaine HCl for postoperative management. Upon completion of the forefoot procedure in the operative room the subject will be entered into the randomization system which will specify whether to inject 10cc (5mg/mL) of bupivacaine HCl or 8cc (13.3 mg/mL) liposomal bupivacaine, both considered routine care procedure. Thereafter, postoperative pain will be assessed and measured using a Visual Analog Scale (VAS) scoring scale post-operatively at 2 hours, 24 hours, 48 hours and 72 hours. In addition, the amount of oral morphine equivalents (OME) required postoperatively and time to first use of OME will be measured. Our hypothesis is that patients who received liposomal bupivacaine will have less post-operative pain and require less OMEs.

NCT ID: NCT04751175 Recruiting - Pain, Postoperative Clinical Trials

Management of Pain in Lumbar Arthrodesis

KETASONA
Start date: July 4, 2013
Phase: Phase 4
Study type: Interventional

KETAMINE AND DEXAMETASONE IN THE MANAGEMENT OF PAIN IN LUMBAR ARTHRODESISPhase IV prospective randomized controlled single-center clinical trial to determine the effect of intravenous ketamine and dexamethasone administration perioperatively in patients undergoing lumbar arthrodesis.

NCT ID: NCT04749628 Recruiting - Knee Osteoarthritis Clinical Trials

Cannabidiol for Bilateral Total Knee Arthroplasty

Start date: November 2, 2022
Phase: Phase 4
Study type: Interventional

In light of the opioid epidemic and evidence suggesting that cannabis may be opioid-sparing, we are in a unique position to conduct a novel, high-impact study that would set the stage for future RCTs examining the effects of a nonintoxicating and nonaddictive cannabinoid in an orthopedic patient population. Epidiolex®, an oral cannabidiol (CBD) solution, is the first ever cannabis-derived medication to be approved by the Food & Drug Administration. Our aim is to conduct a pilot study using a placebo oral solution, 400mg and 800mg Epidiolex® to gather data on its effects on patients undergoing bilateral total knee arthroplasty (BTKA). We will be estimating whether Epidiolex® is associated with minimal opioid use and adequate analgesia. We will also assess its tolerability, pharmacokinetics, and effects on inflammatory markers in the perioperative setting.

NCT ID: NCT04730531 Recruiting - Postoperative Pain Clinical Trials

Postoperative Pain Control Using Local Wound Infiltration in Adolescent Idiopathic Surgery

Start date: June 2, 2022
Phase: N/A
Study type: Interventional

Non-opioid methods of pain management following posterior spinal fusion (PSF) have become increasingly popular given the rise of opioid abuse and opioid-related deaths. Orthopedic surgery remains one of the highest prescribing subspecialties. Local wound infiltration is an effective method of acute pain management following surgical intervention and is the standard in some surgical subspecialties, however, no randomized control trials (RCT) exist in the pediatric spine literature. This would be the first (RCT) to assess the use of local would infiltration in postoperative pain control following PSF for adolescent idiopathic scoliosis patients (AIS). The primary aim of this study is to investigate the efficacy of local wound infiltration with anesthetic agents in reduction of postoperative pain scores and post-operative opioid use during hospital admission following fusion surgery in AIS patients. The proposed single-center, double-blind prospective randomized study will be conducted by recruiting patients meeting the inclusion criteria of age 10-26 years and diagnosis of AIS undergoing posterior fusion surgery. Study participants will be randomized into either a local injection of 0.25% bupivacaine with epinephrine or a placebo of equal volume injectable saline. Patient-reported outcomes will be collected at 1-, 6-, 12- and 24-months postoperatively.

NCT ID: NCT04728308 Recruiting - Postoperative Pain Clinical Trials

Bupivacaine Infiltration and Postoperative Pain

Start date: January 10, 2021
Phase: Early Phase 1
Study type: Interventional

This is a double-blind randomized controlled trial to assess the efficacy of local infiltration of bupivacaine versus placebo, in reducing postoperative pain. The severity of pain will be assessed in terms of mean score on visual analogue scale, opioid requirement and average duration of hospital stay.

NCT ID: NCT04726930 Recruiting - Pain, Postoperative Clinical Trials

Ultrasound Needle Transducer for Regional Anesthesia Validation Study

Start date: December 15, 2020
Phase:
Study type: Observational

To validate the efficacy of miniaturized ultrasound needle transducer as the primary guide for thoracic regional anesthesia.

NCT ID: NCT04724772 Recruiting - Pain, Postoperative Clinical Trials

Use of Tranexamic Acid in Blepharoplasties

Start date: February 20, 2020
Phase: Phase 3
Study type: Interventional

The goal of this investigation is to assess whether or not there is a significant difference in the presence and/or degree of post-operative ecchymosis, pain, and edema between groups of patients undergoing upper lid blepharoplasty with traditional local anesthetic (LA) and those who receive tranexamic acid (TXA) in addition to traditional LA.

NCT ID: NCT04724252 Recruiting - Pain, Postoperative Clinical Trials

Gabapentin to Reduce Opioid Use Postoperatively (GROUP) in Children

Start date: August 23, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

The primary objective of this study is to determine if the peri and post operative use of gabapentin in children reduces the need for narcotics after thoracic surgery. We hypothesize that patients who are given gabapentin will need fewer morphine equivalents postoperatively than those who were not given gabapentin

NCT ID: NCT04718116 Recruiting - Surgery Clinical Trials

Tapentadol Versus Tramadol Analgesia Post Cardiac Surgery

vasso-annie
Start date: November 1, 2022
Phase: N/A
Study type: Interventional

The aim of this randomized one-blinded study will be to evaluate the efficacy and tolerability of two different oral doses of tapentadol and compare it to tramadol (an opioid commonly used to treat post-surgical pain) in cardiac surgery patients

NCT ID: NCT04715165 Recruiting - Postoperative Pain Clinical Trials

Analgesia After Laparoscopic Cholecystectomy

Start date: August 7, 2021
Phase: Phase 2
Study type: Interventional

Pain after laparoscopic cholecystectomy is common and may lead to delayed hospital discharge.